4.5 Article

CIP2A-promoted astrogliosis induces AD-like synaptic degeneration and cognitive deficits

Journal

NEUROBIOLOGY OF AGING
Volume 75, Issue -, Pages 198-208

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.neurobiolaging.2018.11.023

Keywords

CIP2A; Reactive astrogliosis; Synaptic degeneration; Cognitive deficit

Funding

  1. National Natural Science Foundation of China, China [81471304, 31771189]
  2. Natural Science Foundation of Hubei Province, China [2017CFA065]
  3. Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College, HUST
  4. NIH, United States [R01MH079407]

Ask authors/readers for more resources

Reactive astrogliosis and early synaptic degeneration are 2 characteristic hallmarks in Alzheimer's disease (AD) brains, but a direct link between the 2 events has not been established. Here, we show that cancerous inhibitor of PP2A (CIP2A), a cancerous protein with high expression level in astrocytes, is upregulated in patients with AD and 3xTg-AD transgenic mice. Overexpression of CIP2A in astrocytes through adeno-associated virus infection both in cultured cells and in mice brains results in activation of astrocytes, increased production of cytokines and A beta, and synaptic degeneration indicated by decreased levels of synaptic proteins, spine loss, and impairment in long-term potentiation. As a result of synaptic degeneration, CIP2A overexpression in astrocytes in vivo induces significant deficits in visual episodic memory detected by novel objective recognition test and spatial memory detected by Morris water maze. We conclude that CIP2A-promoted astrogliosis induces synaptic degeneration and cognitive deficits in AD. (C) 2018 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Oncology

Discovery of a Novel CIP2A Variant (NOCIVA) with Clinical Relevance in Predicting TKI Resistance in Myeloid Leukemias

Eleonora Makela, Karolina Pavic, Taru Varila, Urpu Salmenniemi, Eliisa Loyttyniemi, Srikar G. Nagelli, Tea Ammunet, Veli-Matti Kahari, Richard E. Clark, Laura L. Elo, Venkata Kumari Bachanaboyina, Claire M. Lucas, Maija Itala-Remes, Jukka Westermarck

Summary: A novel variant of the oncoprotein CIP2A, named NOCIVA, was discovered and found to be clinically relevant in predicting tyrosine kinase inhibitor therapy resistance in myeloid leukemias.

CLINICAL CANCER RESEARCH (2021)

Article Otorhinolaryngology

Evaluation of prognostic biomarkers in a population-validated Finnish HNSCC patient cohort

J. Routila, I Leivo, H. Minn, J. Westermarck, Sami Ventela

Summary: Population validation is crucial for improving the applicability of results to real-life situations in HNSCC studies. Controlling bias in retrospective studies, especially in the heterogeneous tumor environment of HNSCC, is essential for identifying biomarkers for clinical practice. Simple prognostic examination alone may not be sufficient for this purpose.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2021)

Article Biochemistry & Molecular Biology

ChK1 activation induces reactive astrogliosis through CIP2A/PP2A/STAT3 pathway in Alzheimer's disease

Ying Zhou, Xiaoyuan Liu, Shuqing Ma, Nan Zhang, Dichen Yang, Ling Wang, Simin Ye, Qiongying Zhang, Jing Ruan, Jun Ma, Shiyi Wang, Nan Jiang, Zongyuan Zhao, Shujue Zhao, Chenfei Zheng, Xiaofang Fan, Yongsheng Gong, Mahaman Yacoubou Abdoul Razak, Wenting Hu, Jingye Pan, Xiaochuan Wang, Junming Fan, Jianmin Li, Rong Liu, Yangping Shentu

Summary: This study found that the activation of DNA damage-related Checkpoint kinase 1 (ChK1) in Alzheimer's disease leads to overexpression of CIP2A, which in turn causes reactive astrogliosis, neurodegeneration, and exacerbation of AD.

FASEB JOURNAL (2022)

Article Clinical Neurology

Chk1 Inhibition Ameliorates Alzheimer's Disease Pathogenesis and Cognitive Dysfunction Through CIP2A/PP2A Signaling

Wenting Hu, Zhuoqun Wang, Huiliang Zhang, Yacoubou Abdoul Razak Mahaman, Fang Huang, Dongli Meng, Ying Zhou, Shiyi Wang, Nan Jiang, Jing Xiong, Jukka Westermarck, Youming Lu, Jianzhi Wang, Xiaochuan Wang, Yangping Shentu, Rong Liu

Summary: This study reveals that DNA damage-induced Chk1 activation promotes the development of Alzheimer's disease through CIP2A-mediated tau and APP hyperphosphorylation and cognitive dysfunction, highlighting the therapeutic potential of Chk1 inhibitors in AD.

NEUROTHERAPEUTICS (2022)

Article Oncology

Cisplatin overcomes radiotherapy resistance in OCT4-expressing head and neck squamous cell carcinoma

Johannes Routila, Xi Qiao, Jere Weltner, Juha K. Rantala, Timo Carpen, Jaana Hagstrom, Antti Makitie, Ilmo Leivo, Miia Ruuskanen, Jenni Soderlund, Marjut Rintala, Sakari Hietanen, Heikki Irjala, Heikki Minn, Jukka Westermarck, Sami Ventela

Summary: This study identifies OCT4 as a potential biomarker to predict the therapeutic effect of treatment for head and neck squamous cell carcinoma (HNSCC). OCT4 expression in HNSCC tumors is associated with radioresistance, but combination therapy with cisplatin can overcome this resistance. The results of the study are validated using multiple independent patient cohorts.

ORAL ONCOLOGY (2022)

Article Multidisciplinary Sciences

Development of actionable targets of multi-kinase inhibitors (AToMI) screening platform to dissect kinase targets of staurosporines in glioblastoma cells

Oxana Denisova, Joni Merisaari, Amanpreet Kaur, Laxman Yetukuri, Mikael Jumppanen, Carina Von Schantz-Fant, Michael Ohlmeyer, Krister Wennerberg, Tero Aittokallio, Mikko Taipale, Jukka Westermarck

Summary: Therapeutic resistance to kinase inhibitors, particularly in glioblastoma, is a major challenge in cancer treatment. Researchers have developed an actionable targets of multi-kinase inhibitors (AToMI) strategy to identify target kinases involved in the therapeutic effects of multi-kinase inhibitors. Using this strategy, they successfully characterized AKT and mitochondrial pyruvate dehydrogenase kinase PDK1 and PDK4 as target kinases of staurosporine derivatives that synergized with PP2A activation in glioblastoma cells.

SCIENTIFIC REPORTS (2022)

Review Biochemistry & Molecular Biology

Zinc in Regulating Protein Kinases and Phosphatases in Neurodegenerative Diseases

Hui-Liang Zhang, Xiao-Chuan Wang, Rong Liu

Summary: Zinc is crucial for human growth and development, particularly in regulating the mechanisms of neurodegenerative diseases.

BIOMOLECULES (2022)

Article Biochemistry & Molecular Biology

CIP2A deficiency promotes depression-like behaviors in mice through inhibition of dendritic arborization

Wen-Ting Hu, Zhen-Yu Liuyang, Yuan Tian, Jia-Wei Liang, Xiao-Lin Zhang, Hui-Liang Zhang, Guan Wang, Yuda Huo, Yang-Ping Shentu, Jian-Zhi Wang, Xiao-Chuan Wang, You-Ming Lu, Jukka Westermarck, Heng-Ye Man, Rong Liu

Summary: This study discovers a novel mechanism in which CIP2A deficiency promotes depression through the regulation of PP2A-AKT signaling and dendritic arborization. The study also finds decreased expression of CIP2A in a mouse model of chronic unpredictable mild stress (CUMS) and in patients with major depressive disorder (MDD).

EMBO REPORTS (2022)

Article Cell Biology

SHARPIN S146 phosphorylation mediates ARP2/3 interaction, cancer cell invasion and metastasis

Umar Butt, Meraj H. Khan, Jeroen Pouwels, Jukka Westermarck

Summary: This study identifies the role of SHARPIN phosphorylation in cellular processes and cancer progression, with a specific focus on the S146 phosphorylation and its regulation of the ARP2/3 complex interaction, promoting cancer cell invasion.

JOURNAL OF CELL SCIENCE (2022)

Article Oncology

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers

Anna Aakula, Aleksi Isomursu, Christian Rupp, Andrew Erickson, Nikhil Gupta, Otto Kauko, Pragya Shah, Artur Padzik, Yuba Raj Pokharel, Amanpreet Kaur, Song-Ping Li, Lloyd Trotman, Pekka Taimen, Antti Rannikko, Jan Lammerding, Ilkka Paatero, Tuomas Mirtti, Johanna Ivaska, Jukka Westermarck

Summary: This study found that prostate cancer tumors with concomitant inhibition of PP2A and PTEN are particularly aggressive, with low patient survival rates. Overexpression of PME-1 inhibits anoikis in PTEN-deficient prostate cancer cells. The results suggest that PME-1 may be a candidate biomarker for particularly aggressive PTEN-deficient prostate cancer.

MOLECULAR ONCOLOGY (2023)

Article Oncology

Inhibition of adaptive therapy tolerance in cancer: is triplet mitochondrial targeting the key?

Jukka Westermarck

Summary: Targeted therapies are commonly used in cancer treatment, but their effectiveness is limited by acquired drug resistance. Recent studies have highlighted the role of mitochondrial mechanisms in cancer cell sensitivity to targeted therapies, leading to the development of triplet therapies that target vulnerabilities in cancer cells, including the mitochondria. These triplet therapies show promising preclinical effects in overcoming drug resistance, but challenges in clinical translation need to be addressed.

MOLECULAR ONCOLOGY (2023)

Article Multidisciplinary Sciences

Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A

Karolina Pavic, Nikhil Gupta, Judit Domenech Omella, Rita Derua, Anna Aakula, Riikka Huhtaniemi, Juha A. Maatta, Nico Hofflin, Juha Okkeri, Zhizhi Wang, Otto Kauko, Roosa Varjus, Henrik Honkanen, Daniel Abankwa, Maja Kohn, Vesa P. Hytonen, Wenqing Xu, Jakob Nilsson, Rebecca Page, Veerle Janssens, Alexander Leitner, Jukka Westermarck

Summary: This study reveals the molecular level details and structural mechanisms of PP2A-B56 alpha inhibition by the oncoprotein CIP2A. CIP2A displaces the PP2A-A subunit and forms a pseudotrimer, blocking the B56 alpha substrate binding site and stabilizing CIP2A protein.

NATURE COMMUNICATIONS (2023)

Article Biology

RAS and PP2A activities converge on epigenetic gene regulation

Anna Aakula, Mukund Sharma, Francesco Tabaro, Reetta Natkin, Jesse Kamila, Henrik Honkanen, Matthieu Schapira, Cheryl Arrowsmith, Matti Nykter, Jukka Westermarck

Summary: RAS-mediated human cell transformation requires inhibition of PP2A, and the co-regulated phosphosites on proteins involved in epigenetic gene regulation were discovered in this study. RAS and PP2A co-regulate phosphorylation sites on HDAC1/2, KDM1A, MTA1/2, RNF168, and TP53BP1. The study validates the regulation of HDAC1/2 chromatin recruitment, RNF168-TP53BP1 interaction, and gene expression by RAS and PP2A. This work provides insights into the convergence of RAS and PP2A in cancer.

LIFE SCIENCE ALLIANCE (2023)

Meeting Abstract Oncology

Chromatin repressor complex as a converge point of RAS and PP2A activities in lung cancer

Mukund Sharma, Anna Aakula, Francesco Tabaro, Karolina Pavic, Riikka Huhtaniemi, Matti Nykter, Jukka Westermarck

CANCER RESEARCH (2022)

Article Geriatrics & Gerontology

Frontoparietal function and underlying structure reflect capacity for motor skill acquisition during healthy aging

Sarah N. Kraeutner, Cristina Rubino, Jennifer K. Ferris, Shie Rinat, Lauren Penko, Larissa Chiu, Brian Greeley, Christina B. Jones, Beverley C. Larssen, Lara A. Boyd

Summary: This study examined the age-related changes in brain function and baseline brain structure that support motor skill acquisition. The findings showed that older adults experienced decreases in functional connectivity during motor skill acquisition, while younger adults experienced increases. Additionally, regardless of age group, lower baseline microstructure in a frontoparietal tract was associated with slower motor skill acquisition.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Genetic analyses in multiplex families confirms chromosome 5q35 as a risk locus for Alzheimer's Disease in individuals of African Ancestry

Karen Nuytemans, Farid Rajabli, Melissa Jean-Francois, Jiji Thulaseedhara Kurup, Larry D. Adams, Takiyah D. Starks, Patrice L. Whitehead, Brian W. Kunkle, Allison Caban-Holt, Jonathan L. Haines, Michael L. Cuccaro, Jeffery M. Vance, Goldie S. Byrd, Gary W. Beecham, Christiane Reitz, Margaret A. Pericak-Vance

Summary: This study conducted genetic research on African American AD families and identified a significant linkage signal associated with AD, highlighting the importance of diverse population-level genetic data in understanding the genetic determinants of AD.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Improvement of mnemonic discrimination with acute light exercise is mediated by pupil-linked arousal in healthy older adults

Kazuya Suwabe, Ryuta Kuwamizu, Kazuki Hyodo, Toru Yoshikawa, Takeshi Otsuki, Asako Zempo-Miyaki, Michael A. Yassa, Hideaki Soya

Summary: Physical exercise has a positive impact on hippocampal memory decline with aging. Recent studies have shown that even light exercise can improve memory and this improvement is mediated by the ascending arousal system. This study aimed to investigate the effects of light-intensity exercise on hippocampal memory function in healthy older adults and found that pupil dilation during exercise played a role in the memory improvement.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Metformin, age-related cognitive decline, and brain pathology

Ajay Sood, Ana Werneck Capuano, Robert Smith Wilson, Lisa Laverne Barnes, Alifiya Kapasi, David Alan Bennett, Zoe Arvanitakis

Summary: The objective of this study was to explore the impact of metformin on cognition and brain pathology. The results showed that metformin users had slower decline in global cognition, episodic memory, and semantic memory compared to non-users. However, the relationship between metformin use and certain brain pathology remains uncertain.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Sex modifies effects of imaging and CSF biomarkers on cognitive and functional outcomes: a study of Alzheimer's disease

Brian N. Lee, Junwen Wang, Molly A. Hall, Dokyoon Kim, Shana D. Stites, Li Shen

Summary: Alzheimer's disease (AD) is a neurodegenerative disorder characterized by memory and functional impairments. This study analyzed participants from the Alzheimer's Disease Neuroimaging Initiative and found differential associations between cerebral spinal fluid (CSF)/neuroimaging biomarkers and cognitive/functional outcomes, as well as variations between sexes. These findings suggest that sex differences may play a role in the development of AD.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Associations between recall of proper names in story recall and CSF amyloid and tau in adults without cognitive impairment

Madeline R. Hale, Rebecca Langhough, Lianlian Du, Bruce P. Hermann, Carol A. Van Hulle, Margherita Carboni, Gwendlyn Kollmorgenj, Kristin E. Basche, Davide Bruno, Leah Sanson-Miles, Erin M. Jonaitis, Nathaniel A. Chin, Ozioma C. Okonkwo, Barbara B. Bendlin, Cynthia M. Carlsson, Henrik Zetterberg, Kaj Blennow, Tobey J. Betthauser, Sterling C. Johnson, Kimberly D. Mueller

Summary: This study demonstrates a relationship between cerebrospinal fluid biomarkers and the ability to recall proper names in the preclinical phase of Alzheimer's disease.

NEUROBIOLOGY OF AGING (2024)

Article Geriatrics & Gerontology

Auditory robustness and resilience in the aging auditory system of the desert locust

Thomas T. Austin, Christian L. Thomas, Ben Warren

Summary: This study investigated the effects of age on the robustness and resilience of auditory system using the desert locust. The researchers found that gene expression changes were mainly influenced by age rather than noise exposure. Both young and aged locusts were able to recover their auditory nerve function within 48 hours of noise exposure, but the recovery of transduction current magnitude was impaired in aged locusts. Key genes responsible for robustness to noise exposure in young locusts and potential candidates for compensatory mechanisms in auditory neurons of aged locusts were identified.

NEUROBIOLOGY OF AGING (2024)